Labcorp Holdings Inc. (BVMF:L1CA34)

Market Cap	124.66B +2.2%
Revenue (ttm)	73.36B +8.3%
Net Income	4.56B +96.4%
EPS	54.29 +98.4%
Shares Out	n/a
PE Ratio	27.35
Forward PE	16.80
Dividend	2.69 (0.75%)
Ex-Dividend Date	Nov 25, 2025

Volume	3
Average Volume	30
Open	358.66
Previous Close	345.00
Day's Range	358.66 - 358.66
52-Week Range	310.00 - 376.62
Beta	1.04
RSI	58.05
Earnings Date	Feb 17, 2026

About Labcorp Holdings

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1995
• Employees: 70,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: L1CA34

Financial Performance

In 2024, Labcorp Holdings's revenue was $13.01 billion, an increase of 6.97% compared to the previous year's $12.16 billion. Earnings were $746.00 million, an increase of 78.47%.

Financial numbers in USD